VERAXA Biotech
Zurich, Zurich, Switzerland · Biotechnology, Health Care
VERAXA Biotech is a Swiss biotechnology company focused on developing innovative oncology therapies. The company specializes in a proprietary BiTAC platform and is advancing various cancer treatment programs. With its recent entry into public markets, VERAXA aims to enhance its product development and market reach.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Zurich, Zurich, Switzerland
- Employees
- Unknown
- Industries
- Biotechnology, Health Care
- Status
- Public (VRXA)
- Website
- veraxa.com
- Company page
Recent activity at VERAXA Biotech
About VERAXA Biotech: questions and answers
What does VERAXA Biotech do?
VERAXA Biotech is a Swiss biotechnology company focused on developing innovative oncology therapies. The company specializes in a proprietary BiTAC platform and is advancing various cancer treatment programs. With its recent entry into public markets, VERAXA aims to enhance its product development and market reach.
Where is VERAXA Biotech headquartered?
VERAXA Biotech is headquartered in Zurich, Zurich, Switzerland.
What is the latest news on VERAXA Biotech?
On Sep 18, 2026, VERAXA Appoints Raju Willener as Chief Financial Officer
Is VERAXA Biotech a public company?
Yes. VERAXA Biotech is publicly traded under the ticker VRXA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy